Recruiting
Phase 2

Sponsor:

Endeavor Biomedicines, Inc.

Code:

NCT06422884

Conditions

Idiopathic Pulmonary Fibrosis

Progressive Fibrosing Interstitial Lung Disease

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

ENV-101

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by Endeavor Biomedicines, Inc. on 2025-05-29.